toleropharmaceuticals.com toleropharmaceuticals.com

toleropharmaceuticals.com

Tolero Pharmaceutical, Inc.

Alvocidib; CDK9 Inhibitor. TP-0903; AXL Inhibitor. TP-3654; PIM Inhibitor. TP-0184; ALK2 Inhibitor. Tolero Pharmaceuticals, Inc.,. A clinical-stage company, is developing treatments to improve and extend the lives of patients with serious hematological diseases. Tolero Pharmaceuticals Presents Positive Preclinical Data that Inhibition of AXL Kinase Restores Tumor Response to Retinoic Acid. Tolero Pharmaceuticals Presents Positive Preclinical Data on Hepcidin Inhibition for the Treatment of Anemia.

http://www.toleropharmaceuticals.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR TOLEROPHARMACEUTICALS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

August

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.3 out of 5 with 6 reviews
5 star
3
4 star
2
3 star
1
2 star
0
1 star
0

Hey there! Start your review of toleropharmaceuticals.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.2 seconds

CONTACTS AT TOLEROPHARMACEUTICALS.COM

Tolero Pharmaceuticals, Inc. -- Serial Capital

D Anderson

5406 We●●●●●●●0 North

Suite●●●●●3-556

Hig●●●and , Utah, 84003

United States

1.80●●●●5900
da●●●●●●●@toleropharma.com

View this contact

Tolero Pharmaceuticals, Inc. -- Serial Capital

D Anderson

5406 We●●●●●●●0 North

Suite●●●●●3-556

Hig●●●and , Utah, 84003

United States

1.80●●●●5900
da●●●●●●●@toleropharma.com

View this contact

Tolero Pharmaceuticals, Inc. -- Serial Capital

D Anderson

5406 We●●●●●●●0 North

Suite●●●●●3-556

Hig●●●and , Utah, 84003

United States

1.80●●●●5900
da●●●●●●●@toleropharma.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2011 April 14
UPDATED
2012 August 29
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 13

    YEARS

  • 1

    MONTHS

  • 4

    DAYS

NAME SERVERS

1
ns1.powweb.com
2
ns2.powweb.com

REGISTRAR

GODADDY.COM, LLC

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

SCORE

6.2

PAGE TITLE
Tolero Pharmaceutical, Inc. | toleropharmaceuticals.com Reviews
<META>
DESCRIPTION
Alvocidib; CDK9 Inhibitor. TP-0903; AXL Inhibitor. TP-3654; PIM Inhibitor. TP-0184; ALK2 Inhibitor. Tolero Pharmaceuticals, Inc.,. A clinical-stage company, is developing treatments to improve and extend the lives of patients with serious hematological diseases. Tolero Pharmaceuticals Presents Positive Preclinical Data that Inhibition of AXL Kinase Restores Tumor Response to Retinoic Acid. Tolero Pharmaceuticals Presents Positive Preclinical Data on Hepcidin Inhibition for the Treatment of Anemia.
<META>
KEYWORDS
1 about us
2 overview
3 executive management
4 scientific advisory board
5 business advisory board
6 science
7 tolero's pipeline
8 technology
9 sprint discovery platform
10 news and publications
CONTENT
Page content here
KEYWORDS ON
PAGE
about us,overview,executive management,scientific advisory board,business advisory board,science,tolero's pipeline,technology,sprint discovery platform,news and publications,press releases,publications,presentations,posters,business development,careers
SERVER
Apache/2
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Tolero Pharmaceutical, Inc. | toleropharmaceuticals.com Reviews

https://toleropharmaceuticals.com

Alvocidib; CDK9 Inhibitor. TP-0903; AXL Inhibitor. TP-3654; PIM Inhibitor. TP-0184; ALK2 Inhibitor. Tolero Pharmaceuticals, Inc.,. A clinical-stage company, is developing treatments to improve and extend the lives of patients with serious hematological diseases. Tolero Pharmaceuticals Presents Positive Preclinical Data that Inhibition of AXL Kinase Restores Tumor Response to Retinoic Acid. Tolero Pharmaceuticals Presents Positive Preclinical Data on Hepcidin Inhibition for the Treatment of Anemia.

INTERNAL PAGES

toleropharmaceuticals.com toleropharmaceuticals.com
1

Tolero Pharmaceutical, Inc.

http://www.toleropharmaceuticals.com/clinical-trials.html

Alvocidib (CDK9, R/R AML). TP-1287 (Oral CDK9 Inhibitor). TP-0903 (AXL Kinase Inhibitor). TP-0184 (BMPR Signaling Inhibitor). We are currently conducting a Phase II biomarker study. You can learn more about the study at: TPI-ALV-201: ClinicalTrials.gov.

2

Tolero Pharmaceutical, Inc.

http://www.toleropharmaceuticals.com/press06172015.html

Alvocidib (CDK9, R/R AML). TP-1287 (Oral CDK9 Inhibitor). TP-0903 (AXL Kinase Inhibitor). TP-0184 (BMPR Signaling Inhibitor). June 13, 2016 - Tolero Pharmaceuticals Presents Nonclinical Data Demonstrating Alvocidib Provides Drug Combination Strategies Due to the Targeting of MCL-1. June 6, 2016 - Tolero Pharmaceuticals to Present Updates on Clinical and Preclinical Programs at the 2016 EHA Congress. June 6, 2016 - Tolero Pharmaceuticals to Present at the Jefferies 2016 Global Healthcare Conference. Decem...

3

Tolero Pharmaceutical, Inc.

http://www.toleropharmaceuticals.com/posters.html

Alvocidib (CDK9, R/R AML). TP-1287 (Oral CDK9 Inhibitor). TP-0903 (AXL Kinase Inhibitor). TP-0184 (BMPR Signaling Inhibitor). AACR 2015: MCL1 Predicts Response to Alvocidib in AML. AACR 2015: Synergy Between CDK9 and BRD4 Inhibition in AML. AACR 2015: Synergy Between PIM and BTK Inhibition in B-Cell Malignancies. AACR 2015: ALK2 Inhibitors Lower Hepcidin to Treat Anemia. AACR 2015: Profiling Resistance Mechanisms to PIM Kinase Inhibitors.

4

Tolero Pharmaceutical, Inc.

http://www.toleropharmaceuticals.com/business.html

Alvocidib (CDK9, R/R AML). TP-1287 (Oral CDK9 Inhibitor). TP-0903 (AXL Kinase Inhibitor). TP-0184 (BMPR Signaling Inhibitor). Tolero is dedicated to alleviating human suffering by developing novel therapeutics to treat and cure life-threatening diseases. To learn more or to discuss potential opportunities, please contact Joe Nilson at jnilson@toleropharma.com.

5

Tolero Pharmaceutical, Inc.

http://www.toleropharmaceuticals.com/management.html

Alvocidib (CDK9, R/R AML). TP-1287 (Oral CDK9 Inhibitor). TP-0903 (AXL Kinase Inhibitor). TP-0184 (BMPR Signaling Inhibitor). David J. Bearss, Ph.D. Dallin M. Anderson. David W. Sampson. Steven D. Weitman, M.D., Ph.D. Michael V. McCullar, Ph.D. Steven L. Warner, Ph.D. Vice President, Drug Discovery and Development. Michael A. Bernstein, M.P.H. Vice President, Regulatory Affairs.

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

SOCIAL ENGAGEMENT



OTHER SITES

tolerogroup.com tolerogroup.com

Tolero Group | Tolero development group and brokerage

Welcome to Tolero Group. Welcome to Tolero Group. We would like to thank you for visiting the Tolero Group website… Please check back soon or click here…. Leave a Reply Cancel reply. You must be logged in. To post a comment. Tolero development group and brokerage. Proudly powered by WordPress.

tolerohotel.com tolerohotel.com

www.tolerohotel.com

This Web page parked FREE courtesy of Globalias.com. Search for domains similar to. Is this your domain? Let's turn it into a website! Would you like to buy this. Find Your Own Domain Name. See our full line of products. Call us any time day or night .

toleromaeloti.blogspot.com toleromaeloti.blogspot.com

CalhounToler

Wednesday, March 25, 2009. Concrete fountains western pa. Gorham sterling silver flatware. Civil war cannon manufactures. Oneida 66-piece flatware set. Garden lamp post light. Guitar hero faceplate template. Breil domus coffee cappuccino maker. Adobe fireworks cs3 upgrade. Sell trains polar express set. Fujitsu fi 5120c scanner. Tommy hilfiger mens clothes. Buy planet earth hddvd. Kolcraft 3 wheel strollers new. Sketchers girl`s double time. Casio z 1050 digital camera. Fruit of the loom t shirt. Blue An...

toleron.com toleron.com

toleron.com - This website is for sale! - toleron Resources and Information.

The domain toleron.com. May be for sale by its owner! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

toleropharma.com toleropharma.com

Tolero Pharmaceutical, Inc.

Alvocidib; CDK9 Inhibitor. TP-0903; AXL Inhibitor. TP-3654; PIM Inhibitor. TP-0184; ALK2 Inhibitor. Tolero Pharmaceuticals, Inc.,. A clinical-stage company, is developing treatments to improve and extend the lives of patients with serious hematological diseases. Tolero Pharmaceuticals Presents Positive Preclinical Data that Inhibition of AXL Kinase Restores Tumor Response to Retinoic Acid. Tolero Pharmaceuticals Presents Positive Preclinical Data on Hepcidin Inhibition for the Treatment of Anemia.

toleropharmaceuticals.com toleropharmaceuticals.com

Tolero Pharmaceutical, Inc.

Alvocidib; CDK9 Inhibitor. TP-0903; AXL Inhibitor. TP-3654; PIM Inhibitor. TP-0184; ALK2 Inhibitor. Tolero Pharmaceuticals, Inc.,. A clinical-stage company, is developing treatments to improve and extend the lives of patients with serious hematological diseases. Tolero Pharmaceuticals Presents Positive Preclinical Data that Inhibition of AXL Kinase Restores Tumor Response to Retinoic Acid. Tolero Pharmaceuticals Presents Positive Preclinical Data on Hepcidin Inhibition for the Treatment of Anemia.

toleroracing.net toleroracing.net

Tolero Racing

State road race champion! More on how this all played out to come, but 8 Tolero racers in a field of 50 worked hard and Evan Robold made it across the line first. Congratulations, Cat4 State Champion, and congratulations to the whole team that helped make it happen. 2015 State Road Race Champion Evan Robold. 8230;and the complete 8 in Cat 4. Sort of like the solid rocket boosters for the space shuttle, but more powerful. This entry was posted in Announcements. June 22, 2015. A great weekend of racing.

tolerorealestate.com tolerorealestate.com

www.tolerorealestate.com

This Web page parked FREE courtesy of Globalias.com. Search for domains similar to. Is this your domain? Let's turn it into a website! Would you like to buy this. Find Your Own Domain Name. See our full line of products. Call us any time day or night .

toleroservis.hr toleroservis.hr

POČETNA

TOLERO SERVIS d.o.o Bukovačka c. 42a. This email address is being protected from spambots. You need JavaScript enabled to view it. Trebate li servis kućanskih aparata na području grada Zagreba bez ustručavanja nam se obratite. Vršimo popravke kućanskih aparata pouzdano, brzo i povoljno. Klimatizacija bez bakterija - zdrava klimatizacija! Vručine dolaze, pripremite svoju klimatizaciju na vrijeme.

tolerosolutions.com tolerosolutions.com

Home | Tolero Solutions

Success Through People Packages. Project & Program Management. Leadership & Talent. Strategy & Process. Workshops & Training. Success Through People Packages. Project & Program Management. Leadership & Talent. Strategy & Process. Workshops & Training. Achieving success through people. Of employees are unhappy. Every unhappy employee costs on average 1.5 their annual salary to replace. We specialize in. Achieving success through people. By overcoming challenges that impact productivity and profit. We help...

tolerovatjelaska.cz tolerovatjelaska.cz

Tolerovat je láska | Buďte v pohodě se všemi blbci okolo

Být spokojený se vším, jak co je to je oč tu běží. Užívat si každý okamžik, i když lidé a svět kolem je jaký je, a často nás to štve. My vám garantujeme, že to skutečně jde! Pro shlédnutí videí je třeba vyplnit formulář. DĚKUJEME, že nekazíte naši databázi falešnými maily. Vaše údaje jsou v bezpečí. Nemáme rádi spam. Chceme jen, abyste viděli videa a emaily, které vám po přihlášení pošleme. Je možné se kdykoliv odhlásit. Informace o ochraně údajů. 80% lidí se často zlobí! 100% lidí to tak nechce!